Alkermes ALKS
NASDAQ ALKS
$45.24 -0.26 (-0.56%)
As of: Sep 9, 2026 · 2:45 PM EDT

Alkermes (ALKS) Operating Leases (2019 - 2026)

Alkermes' (ALKS) quarterly Operating Leases came in at $62.0 million in Q2 2026, down 6.4% year-over-year from $66.2 million in Q2 2025, and down 2.78% quarter-over-quarter from $63.7 million in Q1 2026.

Analysis

Alkermes (ALKS) Operating Leases (2019 - 2026) Analysis & Trends

Alkermes (ALKS) has reported Operating Leases for 8 consecutive years, with $62.0 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Operating Leases fell 6.4% year-over-year to $62.0 million in Q2 2026; TTM through Jun 2026 was $62.0 million, a 6.4% decrease from a year earlier, with the FY2025 full-year figure at $63.3 million, down 8.82% from the prior year.
  • Operating Leases was $62.0 million for Q2 2026 at Alkermes, down from $63.7 million in the prior quarter.
  • Over five years, Operating Leases peaked at $104.0 million in Q1 2022 and troughed at $62.0 million in Q2 2026.
  • A 5-year average of $76.3 million and a median of $73.3 million in 2024 frame the typical range for Operating Leases.
  • Across the five-year window, Operating Leases dropped 26.76% in 2022 and fell 0.76% in 2023, its largest moves.
  • Over 5 years, Operating Leases stood at $76.3 million in 2022, then declined by 0.76% to $75.7 million in 2023, then fell by 8.37% to $69.4 million in 2024, then fell by 8.82% to $63.3 million in 2025, then slipped by 2.02% to $62.0 million in 2026.
  • The last three Operating Leases figures came in at $62.0 million (Q2 2026), $63.7 million (Q1 2026), and $63.3 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 646.03 Bn 625.27 Bn 17.26 Bn
2 AbbVie 441.99 Bn 435.42 Bn 12.70 Bn
3 Merck 366.30 Bn 359.16 Bn 12.21 Bn
4 Novartis Ag 266.55 Bn 258.86 Bn 11.24 Bn
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn
7 Revolution Medicines 44.13 Bn 44.13 Bn -
8 Incyte 25.53 Bn 20.99 Bn 1.57 Bn
9 United Therapeutics 21.51 Bn 18.85 Bn 683.80 Mn
10 Alkermes 7.56 Bn 6.91 Bn 397.90 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 61.98 Mn
Mar 31, 2026 63.75 Mn
Dec 31, 2025 63.25 Mn
Sep 30, 2025 64.97 Mn
Jun 30, 2025 66.22 Mn
Mar 31, 2025 67.81 Mn
Dec 31, 2024 69.37 Mn
Sep 30, 2024 71.03 Mn
Jun 30, 2024 72.54 Mn
Mar 31, 2024 74.10 Mn
Dec 31, 2023 75.71 Mn
Sep 30, 2023 78.55 Mn
Jun 30, 2023 82.34 Mn
Mar 31, 2023 86.11 Mn
Dec 31, 2022 76.29 Mn
Sep 30, 2022 95.73 Mn
Jun 30, 2022 99.83 Mn
Mar 31, 2022 104.01 Mn
Dec 31, 2021 104.16 Mn
Sep 30, 2021 107.86 Mn